MAI Capital Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
HI
DGM
VPC
JT
ACM
CP
MAI Capital Management's ABVX Position: Q2 2026 in Review
MAI Capital Management sold out of Abivax (ABVX) in Q2 2026, closing a stake of 25 shares — an estimated $2.78K sold.
MAI Capital Management first reported a position in ABVX in Q3 2025 and held it in 3 quarters. The position peaked at $3.51K in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- MAI Capital Management reported no remaining Abivax position as of Q2 2026 after selling out during the quarter.
- MAI Capital Management sold 25 Abivax shares in Q2 2026, an estimated $2.78K.
- MAI Capital Management first reported a position in Abivax in Q3 2025 and held it in 3 quarters.
- MAI Capital Management's Abivax position peaked at $3.51K in Q4 2025.
- 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.